The pain-relieving apparatus has a housing, a stimulating surface, user inputs, and a plurality of ports, such as a battery port and a transcutaneous electrical nerve stimulation (TENS) output connector. The stimulating surface may include a suction ring, vacuum apertures, vibration stimulators, a plate, heat and cold transducer elements, and medicinal holders to provide various approaches for relieving pain. The pain-relieving apparatus may also have a sound speaker for producing nerve stimulating sounds.

The electrical stimulation garment includes an electrical stimulator, a flexible substrate, a plurality of electrical connectors, a plurality of electrodes and a plurality of locators. The electrical stimulation is applied to the body part by the electrical stimulator through the placement of the plurality of electrical connectors in contact with the plurality of electrodes to a prescribed area of the body part as identified by the plurality of locators.

According to aspects disclosed herein, an infusion lead assembly may include a housing including a needle receptacle, a housing lumen, a pin receptacle, and a housing conductive trace; a connector including an connector needle, an internal lumen, a metal pin, and a connector conductive trace, and an infusion lead body including an infusion lumen, an exit port, an internal wire, and a distal electrode. The infusion lead assembly may form an electrical path to transmit electrical signals across the connector conductive trace, the metal pin, the housing conductive trace, the internal wire, and the distal electrode. The infusion lead assembly may form a fluid path to transmit fluid across the internal lumen, the connector needle, the infusion lumen, and the exit port.

Device/system that provides pain relief by delivering stimulation that neither generates action potentials nor completely blocks neural transmission (in the peripheral nerve). The present teachings provide relief by modulating release of neurotransmitters in peripheral nerves to cause neuromodulation at the level of the peripheral nerve (modulation of neural signals in the peripheral nerve). The present teachings provide relief by modulating release of neurotransmitters in peripheral nerves to cause neuromodulation at the level of the peripheral nerve (modulation of neural signals in the peripheral nerve) to alter the frequency of physiologically generated neural transmission.

The invention described herein provides for a portable autonomic nerve system stimulation device that may operate as an “open-loop” or “closed-loop” stimulation system and includes in some embodiments a paired therapy for a disease or condition. Embodiments of the inventive device include at least one stimulation circuit for the generation and delivery of a stimulation, at least one biological signal monitoring apparatus for monitoring a biological state of a user wearing the device, at least one controller in electrical communication with the stimulation circuit and at least one power supply for providing power to the controller and stimulation circuit. Aspects of the invention provides for a portable autonomic nerve system stimulation device which may be worn in the ear, or about the head, of a subject, patient or user.

An electric device for skin treatment, includes: a needle body including needles for drug injection and electrical stimulation treatment and a needle printed circuit board (PCB) connected to the needles; a needle cap provided at a first end of the needle body and having a needle hole through which the needles passes; and a handpiece body having a first end detachably connected to a second end of the needle body. The handpiece body includes: a connection PCB to which a connection member configured to be electrically connected to the needle PCB is coupled; and a connection PCB cable configured to be electrically connected to the connection PCB.

The invention comprises providing electric stimuli, which are generated by forming the following ringing circuit: active electrode—inductive storage unit—passive electrode—interelectrode tissues—active electrode, the electric stimuli creating oscillations which are used as a test signal. In one variant of the method, the electrodes are successively applied (in another variant—moved uniformly) across the skin area. Every time the electrodes-to-skin contact is detected, the oscillation parameters are recorded after a delay. Moreover, the values of parameters can be averaged. The invention allows for both combined and disjointed (i.e. separated) electrode placement. An optimal zone for electropulse therapy is identified by a minimal or maximal value of one or more parameters of the aforementioned oscillations and the use of the principle of small asymmetry. The invention further provides for an increase in the accuracy with which zones optimal for electropulse therapy are identified and localized.

The present application relates to a cannula, comprising a cannula body with a cannula tube and a body part attached to the proximal end of the cannula tube, a control clip having a mounting body with at least one control element, said control clip being attachable laterally on the body part to form a first configuration. In addition, the present applications relates to a cannula body, a contact clip and a control clip of a cannula.

Techniques for providing therapy to a patient via electrical stimulation are described. The techniques include, for example, determining, relative to a start time of providing the electrical stimulation, one or more efficacy times that correspond to an efficacy indicator, determining, according to the efficacy times, efficacy data items for the patient, comparing the efficacy data items with the efficacy indicator, and generating, based on the comparison, a prediction of an expected response to the therapy manifesting in the patient at a prospective time.

A lead introducer includes an integrated sheath/needle including a splittable sheath configured to split a into a first portion and a second portion, a needle having a length and a proximal end region, and a hub coupled to the proximal end regions of the splittable sheath and the needle and configured to split into a first portion and a second portion. The needle is permanently attached to either the first portion of the hub or the first portion of the splittable sheath (or both) so that when the hub is split into the first and second portions, the needle remains attached to the first portion of the hub or the first portion of the splittable sheath.